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Introduction {#sec005}
============

Human papillomavirus (HPV) is responsible for nearly all cases of cervical and anal cancers, approximately 70% of the cancers affecting the vagina, vulva, and oropharynx, and 60% of penile cancers\[[@pone.0206726.ref001]\]. In Brazil, according to recent estimates from the International Agency for Research on Cancer, 8,414 women die from cervical cancer and 18,503 new cases are diagnosed annually, ranking as the 2^nd^ most frequent cancer among women between 15 and 44 years of age in Brazil\[[@pone.0206726.ref002]\].

There are currently three highly effective and safe licensed vaccines against HPV. The World Health Organization has recommended the introduction of HPV vaccines into immunization programme for children and young adults\[[@pone.0206726.ref003]\]. Nevertheless, HPV vaccination coverage has been disappointingly low worldwide, and only 1.4% of all eligible females have received a full-course of HPV vaccination\[[@pone.0206726.ref004]\]. Furthermore, there is inequity in access to HPV vaccines, in high income regions 33.6% of females aged 10--20 years have received the full course of HPV vaccine, compared with only 2.7% in lower income regions\[[@pone.0206726.ref004]\]. Hence, populations of countries carrying most of the burden of HPV-related diseases worldwide have the least access to the vaccines\[[@pone.0206726.ref005]\].

The quadrivalent HPV vaccine was introduced into the National Immunization Programme (NIP) in Brazil in 2014, targeting girls 9 to 13 year of age. Initially, the vaccination was school-based and the schedule included two doses 6 months apart followed by a third dose 60 months later. Later in the first year, a reduced two-dose schedule was adopted and the vaccination delivery changed to a health-clinic based strategy. The programme was extended to boys 11 to 13 years old in 2017. According to NIP data for 2014 to 2017, the cumulative vaccine coverage for the two-dose course in girls was 45.1%, and 72.4% of the targeted female population received at least one dose\[[@pone.0206726.ref006]\]. The coverage for at least one dose in boys was disappointingly low at 20.2%\[[@pone.0206726.ref006]\]. It has been argued that the low uptake of HPV vaccine in Brazil may be due to fear of adverse reactions (following media reports of neurological symptoms in clusters of girls in Brazil), parental vaccine hesitancy, and/or logistical challenges to vaccinating adolescents at health-care centers\[[@pone.0206726.ref007]\]. However, there is no data available to indicate which one of these reasons (or whether combination of them) is to blame for that. Previous studies in other countries show vaccine delays and low uptake related to vaccine hesitancy and barriers in access to vaccines\[[@pone.0206726.ref008]--[@pone.0206726.ref012]\].

The aim of this study was to assess coverage and parental acceptance of the HPV vaccine for adolescent daughters and sons in Brazil after its introduction into the NIP. In addition, we sought to determine factors associated with parental intentions for female and male HPV vaccination.

Methods {#sec006}
=======

We conducted a cross-sectional study in seven Brazilian cities (Belém, Belo Horizonte, Brasília, Porto Alegre, Rio de Janeiro, São Paulo, and Salvador). All five Brazilian regions were included. The interviews were conducted by telephone from July/2015 to October/2016. All participants gave verbal consent prior to commencing the interviews. This study was approved by the Ethics Committee of the Gonçalo Moniz Research Center---CPqGM / FIOCRUZ-BA(Protocol CAAE: 31234914.6.0000.0040; Approval number: 738.720).

Study sample {#sec007}
------------

Our sample size was estimated at 801, based on an estimate of parental acceptance of the HPV vaccine of 75%, the population size of the 7 cities 29,298,142, a 95% confidence interval and 3% margin of error.

Participants were selected by random-digit-dialing. Briefly, we sampled from a computer-generated list of all published telephone numbers in each city selected. Parents in households with children aged 18 years or younger were identified and invited to participate. When an eligible parent was not immediately available, a follow-up appointment was scheduled. If the selected person was unwilling to participate, no substitution was made in that household. Up to 10 callbacks were made to repeated no-answers, busy phone numbers, and answering machines.

Data collection {#sec008}
---------------

All interviewers were trained and certified before study enrollment. A round of pilot testing was conducted prior to data collection to assess and improve question wording. We developed and validated aknowledge, attitude and practices (KAP)\[[@pone.0206726.ref013]\] questionnaire ([S1 Questionnaire](#pone.0206726.s002){ref-type="supplementary-material"} and [S2 Questionnaire](#pone.0206726.s003){ref-type="supplementary-material"}). The questionnaire included 79 items grouped in six categories: socio-demographic data, knowledge, attitudes, health practices, and HPV vaccination. The validity of the questionnaire was assessed by expert analysis (five researchers with substantial experience in field survey and epidemiological studies), semantic analysis, and pre-testing. Prior to data collection, a round of pilot testing was conducted to assess and improve question wording. Thirty pilot interviews were recorded, and then three reviewers listened to each interview of this pilot test, some survey questions were reworded or eliminated, and additional training was provided to interviewers.The expert and the semantic analysis, while considered part of the construction of the questionnaire, were steps in the initial validation of content.

Statistical analysis {#sec009}
--------------------

Characteristics of the study population and parental acceptance of the HPV vaccine were presented as numbers and/or percentages of participants, and stratified by parental acceptance of HPV vaccination. The statistical significance (two-tailed p\<0.05) was assessed by the Chi-square (χ^2^) or Fisher's exact testfor categorical variables. For each assessment about HPV or HPV vaccine, parents' knowledge was arbitrarily classified as "adequate" if 70% or more of the answers were correct, otherwise, knowledge was considered "inadequate".All statistical analyses were performed using Stata Statistical Software (College Station, TX: Stata Corp LP). The dataset is available ([S1 Dataset](#pone.0206726.s001){ref-type="supplementary-material"})

Results {#sec010}
=======

Out of 2,324 eligible parents, 826 completed the interview for a response rate of 35.5%. The majority were women (85%), with a mean age of 43.8 years (range 18 to 82). At the time of the study interview, 37%had at least one daughter/son in the age range for HPV vaccination (9 to 14years)([Table 1](#pone.0206726.t001){ref-type="table"}).

10.1371/journal.pone.0206726.t001

###### Socio-demographic characteristics of 826 parents in Brazil, 2015--2016.
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                                                            n     \%
  --------------------------------------------------------- ----- -----
  Sex (n = 826)                                                   
      Female                                                704   85
      Male                                                  122   15
  Age (n = 787)                                                   
      \< 20 years                                           21    3
      20--29 years                                          94    12
      30--39 years                                          235   30
      40--49 years                                          222   28
      ≥ 50 years                                            215   27
  Race/Ethnicity (n = 786)                                        
      White                                                 346   44
      Mixed                                                 324   41
      Black                                                 106   14
      Asian                                                 8     1
      Indigenous                                            2     0,3
  Marital Status (n = 790)                                        
      Married                                               522   66
      Single                                                156   20
      Divorced or separated                                 75    10
      Widowed                                               37    5
  Religion (n = 791)                                              
      Catholic                                              436   55
      Evangelical / Protestant                              237   30
      Spiritist                                             48    6
      Other                                                 16    2
      No religion                                           54    7
  Current Occupation (n = 788)                                    
      Employed                                              462   59
      Homemaker                                             169   21
      Retired                                               69    9
      Unemployed                                            55    7
      Student                                               33    4
  Educational Attainment (n = 788)                                
      No formal education                                   11    1
      Primary school or less                                145   18
      High school (graduate or some)                        367   47
      College (graduate or some)                            265   34
  Other Characteristics (n = 790)                                 
      Has a daughter in the age range for HPV vaccination   291   37
      Has private health insurance                          435   55
  City (n = 826)                                                  
      Belém                                                 115   14
      Belo Horizonte                                        117   14
      Brasília                                              117   14
      Porto Alegre                                          116   14
      Rio de Janeiro                                        115   14
      Salvador                                              129   16
      São Paulo                                             117   14

Parental Acceptance of HPV vaccine {#sec011}
----------------------------------

The parental acceptance of HPV vaccine for daughters or sons less than 18 years of age was high (92% and 86%, respectively), and did not differ significantly in the different cities surveyed ([Fig 1](#pone.0206726.g001){ref-type="fig"}). Vaccine acceptance for daughters was comparable among mothers and fathers, 92.8% vs. 90.2% (p = 0.319), respectively;the same was also true for sons (mothers:85.9%vs. fathers:84.0%; p = 0.592).

![Parental acceptance of Human Papillomavirus (HPV) vaccination for daughter(s) or son(s)age18 years or less (n = 826), Brazil, 2015 to 2016.](pone.0206726.g001){#pone.0206726.g001}

Knowledge, attitudes and health practices about HPVand the HPV vaccine {#sec012}
----------------------------------------------------------------------

Parents' knowledge about HPV and HPV vaccine was considered adequate for 10 of 21 items assessed (47.6%). Less than one third of parents (30%) knew that there was a vaccine to prevent genital warts, and 37% acknowledged that condoms are not fully protective against HPV infection ([Table 2](#pone.0206726.t002){ref-type="table"}). Parents accepting HPV vaccination were more likely than parents refusing the vaccine to know that: HPV is sexually transmitted, HPV can cause genital warts, HPV vaccine is more beneficial when given before sexual debut, and HPV vaccine most common reactions are minor. Parents accepting HPV vaccine for their daughters but refusing it for their sons were less likely than either parent who accept it for all children or those who refused the vaccine to know that HPV vaccination is recommended for boys ([Table 2](#pone.0206726.t002){ref-type="table"}).

10.1371/journal.pone.0206726.t002

###### Knowledge, attitudes and practices about human papillomavirus (HPV) and the HPV vaccine according to parental acceptance of HPV vaccination, Brazil, 2015--2016.
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                                                                                                                        Total   Parental acceptance of HPV vaccination [^a^](#t002fn001){ref-type="table-fn"}             
  --------------------------------------------------------------------------------------------------------------------- ------- ------------------------------------------------------------------------------- ---- ---- -------------
  **Knowledge items** [^c^](#t002fn003){ref-type="table-fn"}                                                                                                                                                              
  [Transmission of HPV]{.ul}                                                                                                                                                                                              
      HPV is transmitted by sexual contact (T)                                                                          92      94                                                                              90   82   **0.007**
      HPV is spread by airborne transmission (F)                                                                        92      92                                                                              88   88   0.347
      Even without symptoms, someone can transmit HPV (T)                                                               83      84                                                                              83   80   0.762
      HPV is transmitted through use of public bathrooms / pools / showers (F)                                          66      65                                                                              74   67   0.357
      Condom use fully protects against HPV (F)                                                                         37      36                                                                              38   43   0.636
  [Epidemiology and clinical aspects of HPV and cervical cancer]{.ul}                                                                                                                                                     
      HPV can cause cervical cancer (T)                                                                                 86      86                                                                              90   79   0.286
      Cervical cancer is NOT a common cause of cancer death among women (F)                                             75      76                                                                              69   67   0.176
      HPV does not cause cancer in men (F)                                                                              75      76                                                                              73   69   0.511
      HPV can cause genital warts (T)                                                                                   69      71                                                                              61   58   0.055
      Men cannot catch HPV (F)                                                                                          66      66                                                                              67   61   0.771
      HPV can be cured with antibiotics (F)                                                                             62      61                                                                              59   74   0.219
      Someone with HPV usually has symptoms (F)                                                                         58      57                                                                              65   67   0.168
      HPV is a very common virus (T)                                                                                    55      56                                                                              48   61   0.316
  [Primary prevention of HPV / Cervical cancer]{.ul}                                                                                                                                                                      
      A vaccine against HPV already exists (T)                                                                          89      89                                                                              90   82   0.279
      The HPV vaccine works better when it is given before the start of sexual activity (T)                             87      89                                                                              87   67   **\<0.001**
      The HPV vaccine is not for boys (F)                                                                               71      72                                                                              52   79   **0.001**
      The most common reactions from the HPV vaccine are minor, such as pain and discomfort at the injection site (T)   65      66                                                                              71   38   **\<0.001**
      There is a vaccine against cervical cancer (V)                                                                    65      65                                                                              63   71   0.637
      There is no vaccine against genital warts (F)                                                                     30      30                                                                              28   23   0.537
  [Secondary prevention of HPV / Cervical cancer]{.ul}                                                                                                                                                                    
      GIRLS that receive the HPV vaccine do not need to have preventive exams (F)                                       82      82                                                                              76   83   0.425
      If a preventive exam/Pap smear is normal, then a woman does not have HPV (F)                                      64      63                                                                              61   69   0.666
  **Attitudes items** [^d^](#t002fn004){ref-type="table-fn"}                                                                                                                                                              
  [Confidence in vaccines (efficacy/safety)]{.ul}                                                                                                                                                                         
      I generally believe in vaccines                                                                                   96      97                                                                              93   84   **\<0.001**
      I trust the National Immunization Programme                                                                       94      96                                                                              91   71   **\<0.001**
      If the HPV vaccine worked for any age, I would get it                                                             92      94                                                                              93   55   **\<0.001**
      The HPV vaccine is efficacious/ it works                                                                          83      85                                                                              84   43   **\<0.001**
      I don't think the HPV vaccine is safe/ I think it can cause severe reactions                                      21      18                                                                              23   67   **\<0.001**
  [Perception of Risk]{.ul}                                                                                                                                                                                               
      I would give my child a vaccine against a sexually transmitted infection                                          72      74                                                                              71   58   0.066
      I think my DAUGHTER is at risk/has a chance of getting HPV                                                        71      72                                                                              71   57   0.102
      I think my SON is at risk/has a chance of getting HPV                                                             68      72                                                                              36   54   **\<0.001**
      GIRLS between 9 and 13 years are too young to get the vaccine                                                     22      18                                                                              23   67   **\<0.001**
      Getting the HPV vaccine can cause GIRLS to become sexually active much earlier                                    15      14                                                                              16   35   **\<0.001**
  **Health Practices and Medical History** [^e^](#t002fn005){ref-type="table-fn"}                                                                                                                                         
      Have had a cervical cancer screening Pap test at least once before [^f^](#t002fn006){ref-type="table-fn"}         92      93                                                                              85   93   0.109
      Have had a cervical cancer screening Pap test in the past three years [^f^](#t002fn006){ref-type="table-fn"}      83      84                                                                              75   90   0.146
      Have had the Diphtheria, Tetanus, and Pertussis vaccine                                                           69      70                                                                              63   68   0.52
      Have had the Hepatitis B vaccine                                                                                  66      66                                                                              63   68   0.803
      Know other parents who had their children vaccinated with HPV vaccine                                             59      61                                                                              58   40   **0.022**

^a^All parents had at least one child age \<18 years old (boy or girl). Thus, the context of having a child for whom they decide about vaccination is always real, but the parental responses regarding either girls or boys can be hypothetical.

^b^The total (n = 807) represents participants responding to these items.

^c^Percentage of parents with correct answers regarding the statements (True or false).

^d^Percentage of parents who agreed with the statement.

^e^Percentage of parents responding affirmatively.

^f^Data refer only to female participants.

Parental attitudes significantly associated with HPV vaccine acceptance included: beliefs in vaccines in general, trust in the NIP, belief in the efficacy of HPV vaccine, and willingness to receive the HPV vaccine if recommended. In contrast, parents were more likely to refuse HPV vaccination if they believed that: HPV vaccine is not safe or can cause severe reactions, girls age 9 to 13 years are too young to get HPV vaccine, and HPV vaccination can cause girls to become sexually active earlier. Parents refusing HPV vaccine for boys were less likely to perceive their sons as being at risk of getting HPV infection ([Table 2](#pone.0206726.t002){ref-type="table"}).

Knowing other parents who had their children vaccinated against HPV was associated with accepting HPV vaccination. Most mothers in our survey have had a cervical cancer-screening test performed at least once in their lifetime (92%) or in the past three years (83%). A full course of diphtheria, tetanus and pertussis vaccine or hepatitis B vaccine was reported by 69% and 66% of the study participants, respectively ([Table 2](#pone.0206726.t002){ref-type="table"}). None of these health practices was associated with acceptance of HPV vaccination.

Reasons for acceptance or refusal of HPV vaccination {#sec013}
----------------------------------------------------

The reasons for parental acceptance or refusal of human papillomavirus (HPV) vaccination, using open-ended questions to elicit spontaneous responses, are presented in [Table 3](#pone.0206726.t003){ref-type="table"}. The most common motive for accepting vaccination for daughters and sons was that "vaccination is good/important" cited as the primary reason by 90% of the parents, and as one of the reasons by 96% of them. Cancer prevention was the second most common reason cited by only 7% of parents as the primary reason, and as one of them by 10%. Parents accepting HPV vaccination for girls but refusing it for boys cited cancer prevention more often, either as the primary reason (15%) or as one of the reasons (22%).

10.1371/journal.pone.0206726.t003

###### Frequency distribution (%) of the reasons for acceptance or refusal of human papillomavirus (HPV) vaccination reported by parents, using open-ended questions to elicit spontaneous responses,n = 804, Brazil, 2015--2016.
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  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                    Parents accepting vaccination of daughters and sons (n = 687)   Parents accepting vaccination of daughters but not of sons (n = 68)   Parents refusing vaccination\             
                                                                                                                                                                                                                          (n = 49)                                  
  --------------------------------------------------------------------------------- --------------------------------------------------------------- --------------------------------------------------------------------- ------------------------------- ---- ---- ----
  [**Reasons for acceptance of HPV vaccination**]{.ul}                                                                                                                                                                                                              

  Vaccination is good/important                                                     90                                                              96                                                                    82                              88   NA   NA

  HPV vaccination prevents cervical cancer [^a^](#t003fn002){ref-type="table-fn"}   7                                                               10                                                                    15                              22   NA   NA

  The HPV vaccine is included in the national immunization programme                3                                                               3                                                                     1                               4    NA   NA

  HPV vaccination prevents genital warts [^b^](#t003fn003){ref-type="table-fn"}     1                                                               2                                                                     1                               1    NA   NA

  My doctor recommended the HPV vaccine                                             0.3                                                             0.6                                                                   0                               0    NA   NA

  [**Reasons for refusal of HPV vaccination**]{.ul}                                                                                                                                                                                                                 

  The HPV vaccine is not recommended for boys                                       NA                                                              NA                                                                    74                              78   0    0

  Fear of reactions or adverse effects                                              NA                                                              NA                                                                    3                               10   51   61

  I don't like/believe in vaccines                                                  NA                                                              NA                                                                    0                               2    12   18

  My daughter/son is too young                                                      NA                                                              NA                                                                    4                               4    12   14

  My daughter/son doesn't need the HPV vaccine                                      NA                                                              NA                                                                    6                               6    8    8

  My religion doesn't approve the HPV vaccine                                       NA                                                              NA                                                                    0                               0    6    6

  My doctor didn't recommend the HPV vaccine                                        NA                                                              NA                                                                    2                               2    4    4

  Other reason(s) not specified                                                     NA                                                              NA                                                                    12                              12   6    6
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NA = Not applicable.

^**a**^25.1% of parents who accepted vaccination of daughters/sons and 37.7% of parents who accepted vaccination of daughters only, knew that the HPV vaccine prevents cancer

^b^ 9.7% of parents who accepted vaccination of daughters/sons and 2.9% of parents who accepted vaccination of daughters only, knew that the HPV vaccine prevents genital warts

The most common reason for refusing HPV vaccination for both children was "fear of reactions or adverse events" reported as the primary reason by 51% of the parents, and as one of them by 61%. Among parents refusing HPV vaccination for sons (but accepting it for daughters), the reason most commonly reported was "the HPV vaccine is not recommended for boys" (74% as the primary reason and 78% as one of them).

HPV vaccination in the National Immunization Programme (NIP) {#sec014}
------------------------------------------------------------

Out of 291 parents with a daughter eligible to receive the HPV vaccine through the NIP (9 to 14 years of age),170 (58.4%) reported their daughter had completed the two-dose schedule, and 207 (71.1%) had received at least one dose ([Table 4](#pone.0206726.t004){ref-type="table"}). The most common reason reported for not having a daughter vaccinated or for not having them complete the two-dose regimen was "no vaccination/missed vaccination at school" (51.2% and 75.7% respectively).

10.1371/journal.pone.0206726.t004

###### Human papillomavirus (HPV) vaccination coverage among girls 9 to 14 years of age in the National Immunization Programme (NIP) reported by parents (n = 291), Brazil, 2015--2016.

![](pone.0206726.t004){#pone.0206726.t004g}

                                                                           n     \%
  ------------------------------------------------------------------------ ----- ------
  Vaccination of daughter(s) against HPV (n = 291)                               
      Yes (at least one dose) [^a^](#t004fn001){ref-type="table-fn"}       207   71.1
      No                                                                   84    28.9
  Reasons for not vaccinating daughter(s) in the NIP (n = 84)                    
      No vaccination/missed vaccination at school                          43    51.2
      My daughter is too young                                             21    25.0
      I don't believe in vaccines/I am against vaccines                    16    19.0
      My daughter does not need the vaccine                                15    17.9
      Fear of adverse effects/reactions                                    8     9.5
      My religion does not permit HPV vaccination                          1     1.2
      My doctor did not recommend the HPV vaccine                          1     1.2
      Other logistic/access barriers                                       12    14.3
  Reasons for not getting the second dose of HPV vaccine (n = 37)                
      No vaccination/missed vaccination at school                          28    75.7
      Went to a primary health-care center, but could not get vaccinated   7     18.9
      I thought that one dose was enough                                   3     8.1
      Other                                                                5     13.5

^a^170of291 received two doses 58.4%.

Discussion {#sec015}
==========

One year after the inclusion of HPV vaccine in the Brazilian NIP, most parents surveyed were accepting of the HPV vaccination for their daughters (92%) or sons (86%) at the recommended age. Despite the high parental acceptance of HPV vaccine for both daughters and sons, HPV vaccination coverage in Brazil remains only modest for girls (45.1%) and quite poor for boys (16.5%)\[[@pone.0206726.ref006]\].

Acceptance of the HPV vaccine for girls was also high among parents in Indonesia (96%)\[[@pone.0206726.ref014]\] and in the US (75%)\[[@pone.0206726.ref015]\]. In contrast, the level of HPV vaccine acceptance among inner city Caribbean and African American adolescents (44.5%) and their parents (37.5%) was overall lower than what has been reported among other racial/ethnic populations\[[@pone.0206726.ref016]\]. Parental acceptance of male HPV vaccination in our study population was higher than in France (49%), and comparable to estimates reported in the UK (75%), Germany (72%), and Italy (70%)\[[@pone.0206726.ref017]\]. Similarly, a nationally representative random sample of 450 Danish parents showed that HPV vaccination of sons was accepted by 80% of respondents\[[@pone.0206726.ref018]\]. Of note, the survey design of these studies was different from ours in one important aspect: the investigators gave parents information about the main direct benefits of male vaccination, before asking them about their views on HPV vaccination of their sons. Thus, one should be cautious when comparing vaccine acceptance rates from such studies to estimates from those offering parents no information about HPV vaccine prior to the survey. In studies similar to ours, parental acceptance was lower in two surveys in the U.S. (43%\[[@pone.0206726.ref019]\] and 39%\[[@pone.0206726.ref020]\]) and comparable to ours in the UK(79%)\[[@pone.0206726.ref021]\], while in Italy, 71% of parents revealed their intentions to vaccinate their sons against HPV, but only 53.7% reported that their daughters had been vaccinated\[[@pone.0206726.ref022]\].

HPV vaccine acceptance did not differ substantially by sex of child in two large reviews, although a preference of parents and health care providers to vaccinate females over males was reported in the majority of studies reviewed\[[@pone.0206726.ref023],[@pone.0206726.ref024]\]. Nevertheless, many studies included in these reviews were based on the hypothetical availability of an HPV vaccine for boys, and results may not indicate actual acceptance. It was somehow surprising to find high parental acceptance of HPV vaccine for sons in our survey, given that the HPV vaccine was mainly marketed in Brazil as a cancer vaccine for girls, and that parents had limited information about HPV infection in men and its consequences for male health\[[@pone.0206726.ref017],[@pone.0206726.ref025]\].

Knowledge about HPV and HPV vaccine was fair in our study population. Although most parents knew about HPV and its association with cervical cancer in women and other cancers in men, this knowledge was not associated with acceptance of HPV vaccination for daughters or sons. Some studies have suggested that parents accept the value of HPV vaccine's role in cancer prevention\[[@pone.0206726.ref016],[@pone.0206726.ref026]\]. In a survey of urban Indian parents, only 27% of men and 24% of women agreed to vaccinate their daughters against HPV; but, after going through an educational fact sheet about cervical cancer and the HPV vaccine, 74% of both men and women were in favor of vaccination\[[@pone.0206726.ref027]\]. Yet, knowing that HPV causes cervical cancer may not be sufficient for parents to accept HPV vaccination, as most parents rejecting vaccination in our survey were aware of this association. Relatively few parents in our study (10%) cited cancer prevention as one of the reasons to accept HPV vaccination, given that most (86%) knew about the link between HPV and cervical cancer. It is possible that parents perceive cancers occurring later in life as less important on their decision to accept a vaccine given to pre-adolescents/adolescents than other severe diseases, such as meningitis, which might be viewed as a more serious and immediate threat to their children.

In our study, parents who knew that HPV vaccine is more beneficial when given before sexual debut were more likely to accept HPV vaccination (as well as parents who agreed to give their child a vaccine against a STI). Some studies have suggested that parents' concerns about offering their child a vaccine to prevent sexually transmitted infections and parents' beliefs that HPV vaccine would promote promiscuity as reasons for not vaccinating\[[@pone.0206726.ref028]--[@pone.0206726.ref030]\]. There has been controversy regarding the alleged role of HPV vaccine in promoting sexual activity. Concerns among parents about the vaccine's effect on sexual behavior were reported in a review of barriers to HPV vaccination among US adolescents\[[@pone.0206726.ref031]\]. Our results suggest that knowledge about HPV sexual transmission did not lead parents to refuse HPV vaccination, but rather made them more likely to accept it. Differences in study populations may account for these diverse findings.

In our survey, parents who knew that HPV vaccine is effective and generally safe were more likely to accept vaccination, as shown in previous studies\[[@pone.0206726.ref015],[@pone.0206726.ref026],[@pone.0206726.ref032]\]. Additionally, trust in vaccines in general and in the NIP were important correlates of parental acceptability. It has been shown that parents in countries with active vaccination policies tended to trust the importance of NIPs, while those in countries with passive vaccination strategies had a greater need for information from health care professionals and public health authorities\[[@pone.0206726.ref017]\].

General belief in vaccination was the primary reason for parental acceptance of HPV vaccine in our survey. In contrast, a study of a representative sample of parents in the State of California found a much smaller proportion (4.9%) reporting a general belief in recommended vaccinations as one of the reasons for being likely to vaccinate\[[@pone.0206726.ref015]\]. In our study, parents' perceptions about vaccines in general were cited more often in their decision to vaccinate than their perceptions about diseases or disease susceptibility. Furthermore, fear of vaccine side effects and distrust in vaccines were the most commonly given reason to refuse HPV vaccination reported in our study. Since parents' decision to vaccinate children was mainly based on their general belief in vaccines, acceptance rates maydecline if parents are confronted by false arguments against vaccination from anti-vaccination narratives\[[@pone.0206726.ref033]\].

As far as we know, this is the first population-based survey of HPV vaccine coverage in Brazil since its introduction in the NIP. Our estimates of vaccine coverage for the two-dose course (58%) and for at least one dose (71%) were similar to the ones provided by the NIP, 45% and 72%, respectively\[[@pone.0206726.ref006]\]. The programme achieved a high coverage (\>90%) for the first dose of HPV vaccination early in 2014, when the NIP used a school-based vaccine delivery,but was less than 50% for the second dose later in the same year\[[@pone.0206726.ref034]\]. It was not clear whether this reduction was caused by an increase in parental vaccine refusal (after the report of clusters of cases of lower limbs paralysis following receipt of HPV vaccine at two schools, interpreted as a mass psychogenic reaction)\[[@pone.0206726.ref007]\] or it was caused by the change in vaccine delivery from school to health center based strategy, or both\[[@pone.0206726.ref034]\]. Our results show that parental acceptance of HPV vaccine in Brazil remains high, as does trust of parents in the NIP and its recommended vaccines. School-based approaches to adolescent vaccination implemented in the UK and Australia have achieved high coverage, while approaches based in health care delivery settings tend to be less successful\[[@pone.0206726.ref035]\]. Moreover, two thirds of parents missing vaccination of their daughter(s) in our study reported either no vaccination at school or other barriers related to vaccine access as the reasons for that. Therefore, only one third of them had actually refused HPV vaccination. Similarly, nearly all parents missing their daughter(s) second-dose of the HPV vaccine reported barriers related to vaccine access at the health care settings as the reason for not completing the vaccination schedule. It is likely that the low coverage of HPV vaccination in Brazil are due to challenges in adolescent vaccine delivery and HPV vaccination barriers at health-care centers, rather than to an increase in parental vaccine refusal.

Strengths and limitations {#sec016}
-------------------------

Our study had several strengths, including the use of a national sample, and refining our survey instrument extensively through cognitive testing and pretesting. In addition, we did not inform parents about the vaccine's potential health benefits for females and males before asking them about their views on HPV vaccination (which could have affected vaccine acceptability among study participants). Finally, most studies of attitudes about HPV vaccination come out of high-income countries. We provided much needed research examining HPV vaccination in general and opinions about male vaccination in a middle-income country.

There are many limitations to this study. First, we reported on individual items and have not attempted to combine items in subscales to examine each construct impacted on decision making. Also, one cannot be sure about how the results obtained via a telephone interview might translate into real-life decisions, where medical information and conversation with family will influence parents' decision process. The response rate (35%) is low and may not seem sufficient to generalize the results to the target population, however, this number is relatively high for a telephone survey. According to the American Association for Public Opinion Research the average telephone response rate in 2015 for the U.S.A was 9.3%\[[@pone.0206726.ref036]\]. Moreover, refusals in telephone surveys tend to be driven by general unwillingness to participate and non-biased. Thus, it is not likely to have distorted our estimates. In addition, because our estimates of HPV vaccine uptake were based on self-reported data and willingness levels, they may overstate future vaccination behavior, as intent does not always lead to behavior\[[@pone.0206726.ref037]\]. However, we also provided data on actual vaccination behavior from the subset of parents with daughters in the recommended vaccination age range. Also,more than half of the parent in our sample had children under 9 and so they may have not yet started engaging with thinking about the vaccine. The negative wording of the questions regarding males might have had a negative bias on parent\'s responses. Lastly, we assumed that parents will be the principal decision makers concerning female and male adolescent vaccination and have not examined adolescents\' attitudes about receipt of HPV vaccine. Nonetheless, it may be important to assess how parents and adolescents make decisions about HPV vaccination together.

Conclusions {#sec017}
===========

Our study shows that most parents in Brazil are interested in vaccinating their daughters and sons against HPV. Nevertheless, HPV vaccination coverage in the NIP remains low. Barriers to access to vaccination in health care settings are likely the main reason for low HPV vaccine uptake, therefore changing back to a school-based vaccine delivery would likely improve vaccine coverage. Regardless of the vaccination strategies adopted, more efforts should be made to educate parents and adolescents about HPV infection and its implications for male and female health\[[@pone.0206726.ref011],[@pone.0206726.ref038],[@pone.0206726.ref039]\]. As for those refusing the vaccine, confidence in vaccines and perception of risk are important, while for those who vaccinate daughters but not sons, understanding about the vaccine as it pertains to males is important. The modifiable factors identified here should be targeted in future interventions to increase HPV vaccine uptake among both males and females in Brazil.
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